Valuing early-stage companies is art, not science. The speaker, who spent two years on valuations at Arthur Andersen, favors practical shortcuts: back-calculate from the investor's desired stake and check size, or benchmark against comparable companies. A slide deck shows typical valuation ranges by financing round.
valuation is an art, not a science at the early stage, right? You can build cash flow models, discounted cash flow models, market multiple models. I used to— I got my start working in valuation at a firm called Arthur Andersen, right? One of the large, like, big 5 accounting firms. All I did for 2 years was valuation of early stage companies. And we would do, you know, these, these models to support it. But really, it's an art, not a science. You know, the best way to approach this is to kind of just look at a couple of different ways. One is look at what sort of equity the investor is trying to get for a certain dollar amount, like they want to have 20% ownership and their typical check size is X, you know, you can kind of back into a valuation that way. The other is looking at comps in the space. That same slide deck I showed has some details on like kind of typical valuations at different rounds.
